Clinical Trial Update: A Study to Investigate the Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With GSK3036656 in Female Participants of Non-childbearing Potential Aged 18 to 65 Years of Age [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating a combined oral contraceptive alone and in combination with GSK3036656 in female participants of non-childbearing poten…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Combined oral contraceptive
• GSK3036656

Snippet

Sponsor: GlaxoSmithKline | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED | Results posted: 2025-08-26